Progenika Biopharma
Molecular biology tests, Autoimmunity, Immunohaematology, Genetic cardiovascular diseases, Genetic pulmonary diseases, COVID-19.
Molecular biology tests, Autoimmunity, Immunohaematology, Genetic cardiovascular diseases, Genetic pulmonary diseases, COVID-19.
Automation, Mechanisation, Hospitals, Pharmacy, Drug dosing, Drug preparation.
Microarrays, Cell membrane, Radioligand binding, Immunoassays, Enzyme activities, Customised microarrays, Functionalisation of surfaces and biosensors, Miniaturisation of ELISAs, Pharmacodynamic analysis, Mitochondrial toxicity, Lipidomics by mass spectrometry.
Nanohydrogels, Controlled release, Encapsulation, Coatings, Development for third parties, Injectable hyaluronic acid, Consultancy, Own product